Pacira BioSciences (PCRX) Current Assets (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Current Assets of $515.0 million for Q1 2026, down 32.24% year-over-year from $760.0 million in Q1 2025, and down 6.02% quarter-over-quarter from $548.0 million in Q4 2025.
Pacira BioSciences (PCRX) Current Assets (2010 - 2026) Analysis & Trends
Pacira BioSciences' Current Assets history runs 17 years deep, the most recent figure standing at $515.0 million for Q1 2026.
- In Q1 2026, Current Assets fell 32.24% year-over-year to $515.0 million; the TTM figure through Mar 2026 stood at $515.0 million (down 32.24% YoY), while the FY2025 annual figure was $548.0 million, down 26.46% from the prior year.
- Current Assets for Q1 2026 stood at $515.0 million, down from $548.0 million in the prior quarter.
- The five-year high for Current Assets was $760.0 million in Q1 2025, with the low at $376.1 million in Q1 2023.
- The 5-year median for Current Assets is $543.1 million (2024), against an average of $572.3 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 43.61% in 2023, then soared 54.27% in 2024.
- Pacira BioSciences' Current Assets stood at $498.3 million in 2022, then advanced by 2.34% to $510.0 million in 2023, then surged by 46.11% to $745.1 million in 2024, then fell by 26.46% to $548.0 million in 2025, then retreated by 6.02% to $515.0 million in 2026.
- Business Quant data shows PCRX's Current Assets at $515.0 million in Q1 2026, $548.0 million in Q4 2025, and $562.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Pacira BioSciences | 939.59 Mn | 688.56 Mn | 148.24 Mn | 615.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 615.22 Mn |
| Mar 31, 2026 | 514.96 Mn |
| Dec 31, 2025 | 547.97 Mn |
| Sep 30, 2025 | 562.75 Mn |
| Jun 30, 2025 | 745.61 Mn |
| Mar 31, 2025 | 759.96 Mn |
| Dec 31, 2024 | 745.13 Mn |
| Sep 30, 2024 | 689.97 Mn |
| Jun 30, 2024 | 632.21 Mn |
| Mar 31, 2024 | 543.11 Mn |
| Dec 31, 2023 | 509.99 Mn |
| Sep 30, 2023 | 447.26 Mn |
| Jun 30, 2023 | 429.32 Mn |
| Mar 31, 2023 | 376.11 Mn |
| Dec 31, 2022 | 498.33 Mn |
| Sep 30, 2022 | 533.41 Mn |
| Jun 30, 2022 | 526.21 Mn |
| Mar 31, 2022 | 667.02 Mn |
| Dec 31, 2021 | 866.05 Mn |
| Sep 30, 2021 | 822.35 Mn |